47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
78.30.Z - Employment activities
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,1 | 1,8 | 0,3 | -82,5 |
EBITDA | 2,9 | 2,4 | 0,6 | -73,5 |
Short time liabilities | 13,6 | 12,2 | 6,7 | -44,9 |
Equity capital | 2,2 | 1,8 | 0,3 | -81,6 |
Operating profit (EBIT) | 2,2 | 1,9 | 0,4 | -81 |
Assets | 16,4 | 14,6 | 7,4 | -49,1 |
Net profit (loss) | 2,1 | 1,8 | 0,3 | -82,5 |
Cash | 1,2 | 0,1 | 0,2 | 104,7 |
Net income from sale | 39,6 | 43,7 | 43,7 | 0 |
Liabilities and provisions for liabilities | 14,3 | 12,8 | 7,1 | -44,5 |
Working assets | 6,1 | 5,6 | 5,2 | -6,8 |
Depreciation | 0,7 | 0,5 | 0,3 | -42 |
% | % | % | p.p. | |
Profitability of capital | 99,1 | 98,9 | 94 | -4,9 |
Equity capital to total assets | 13,2 | 12,4 | 4,5 | -7,9 |
Gross profit margin | 5,4 | 4,1 | 0,7 | -3,4 |
EBITDA Margin | 7,4 | 5,4 | 1,4 | -4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 125 | 102 | 56 | -46 |
Current financial liquidity indicator | 0.43272864818573 | 0.4459085464477539 | 0.7366087436676025 | 0,3 |
Net dept to EBITDA | 0.7223418354988098 | 0.6891914010047913 | -0.26090705394744873 | -1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane